These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 454545)

  • 21. A short series of antidiabetic sulfonylureas exhibit multiple ligand PPARgamma-binding patterns.
    Arrault A; Rocchi S; Picard F; Maurois P; Pirotte B; Vamecq J
    Biomed Pharmacother; 2009 Jan; 63(1):56-62. PubMed ID: 18280694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and antidiabetic activity of new 3-methyl-5-phenylpyrazolesulfonylurea derivatives.
    Soliman R; Feid-Allah HM
    J Pharm Sci; 1981 Jun; 70(6):602-5. PubMed ID: 6788934
    [No Abstract]   [Full Text] [Related]  

  • 23. Preparation and antidiabetic activity of new substituted 3,5-diarylpyrazolesulfonylurea derivatives.
    Soliman R; Feid-Allah HM; El Sadany SK; Mohamed HF
    J Pharm Sci; 1981 Jun; 70(6):606-10. PubMed ID: 6788935
    [No Abstract]   [Full Text] [Related]  

  • 24. Sulfamylurea hypoglycemic agents. 6. High-potency derivatives.
    Sarges R; Kuhla DE; Wiedermann HE; Mayhew DA
    J Med Chem; 1976 May; 19(5):695-709. PubMed ID: 1271411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentially active hypoglycemic agents from N1-nicotinoyl-2-pyrazolin-5-one derivatives and their N1-(oxynicotinoyl) analogues.
    Girges MM; Hanna MA; Rasala D; Berghot M
    Arzneimittelforschung; 1992 Nov; 42(11):1350-3. PubMed ID: 1492850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents.
    Zhang HB; Zhang YA; Wu GZ; Zhou JP; Huang WL; Hu XW
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1740-4. PubMed ID: 19216076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New N1-acyl-N4-arylthiosemicarbazides with therapeutic action. 3. Phenylthiosemicarbazides of alpha-(para-acetylaminophenylamide)-cinnamic acid with spasmolytic effect].
    Demetrescu C; Manu V; Chirită C
    Pharmazie; 1970; 25(5):317-9. PubMed ID: 5455410
    [No Abstract]   [Full Text] [Related]  

  • 28. Biological properties of N4- and N1,N8-spermidine derivatives in cultured L1210 leukemia cells.
    Porter CW; Cavanaugh PF; Stolowich N; Ganis B; Kelly E; Bergeron RJ
    Cancer Res; 1985 May; 45(5):2050-7. PubMed ID: 3921235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
    Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
    Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synthesis of therapeutic 1,3,4-thiadiazoles by acid catalysed cyclization of N1-acyl-N4-arylthiosemicarbazides of cinnamic acid].
    Demetrescu C; Manu V; Răcăşanu R
    Pharmazie; 1970 Jul; 25(7):409-11. PubMed ID: 5455431
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis of some novel N4-(naphtha[1,2-d]thiazol-2-yl)semicarbazides as potential anticonvulsants.
    Azam F; Alkskas IA; Khokra SL; Prakash O
    Eur J Med Chem; 2009 Jan; 44(1):203-11. PubMed ID: 18396352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Compounds and reactions of sulfonamides with amines. 13. Synthesis of some derivatives of N-(benzenesulfonyl)-delta 2-pyrazoline-1-carboxamide].
    Brzozowski Z
    Acta Pol Pharm; 1974; 31(3):301-4. PubMed ID: 4848358
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 34. Syntheses of some 4-[(4-chloro-5-methyl-2-methylthiophenyl)sulphonyl]-1-(aryl)semicarbazi des and N-[(4-chloro-5-methyl-2-methylthiophenyl)sulphonyl]-N'-(4-chlorophenyl) urea with potential anticancer activity.
    Brzozowski Z
    Acta Pol Pharm; 1998; 55(3):233-8. PubMed ID: 9735704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New compounds and reactions of sulfonamides with amines. XII. Synthesis of some derivatives of N-(benzenesulfonyl)-delta 2-pyrazoline-1-carboxamide].
    Brzozowski Z
    Acta Pol Pharm; 1974; 31(3):293-9. PubMed ID: 4849239
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
    Wrobel J; Li Z; Dietrich A; McCaleb M; Mihan B; Sredy J; Sullivan D
    J Med Chem; 1998 Mar; 41(7):1084-91. PubMed ID: 9544208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new class of high ceiling diuretics : derivatives of 1-alkyl-3-(4-phenylaminopyridin-3-yl)sulfonylurea (author's transl)].
    Delarge J; Lapière CL
    Ann Pharm Fr; 1978; 36(7-8):369-79. PubMed ID: 742814
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolism of glipizide in the rat and dog and its tissue distribution in the mouse.
    Goldaniga GC; Maraone C; Pianezzola E; Valzelli G; Ambrogi V
    Arzneimittelforschung; 1973 Feb; 23(2):242-7. PubMed ID: 4739837
    [No Abstract]   [Full Text] [Related]  

  • 39. Derivatives of 4,5,6,7-tetrahydro-7,8,8-trimethyl-3-phenylamino-4,7-methano-2H-ind azo le with hypotensive and hypoglycemic activities. II.
    Ranise A; Bondavalli F; Schenone P; Lampa E; Greco R; Scafuro M; Marmo E
    Farmaco Sci; 1984 Mar; 39(3):200-7. PubMed ID: 6714414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological activity of 4-thiazolidinones, thiosemicarbazides derived from diflunisal hydrazide.
    Küçükgüzel G; Kocatepe A; De Clercq E; Sahin F; Güllüce M
    Eur J Med Chem; 2006 Mar; 41(3):353-9. PubMed ID: 16414150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.